These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 10957774)

  • 1. [Early detection of prostatic carcinoma in urologic practice with digital rectal examination and prostate-specific antigen. Early Detection Project Group].
    Luboldt HJ; Hüsing J; Altwein JE; Bichler KH; Czaja D; Fornara P; Jöckel KH; Schalkhäuser K; Weissbach L; Wirth M; Rübben H
    Urologe A; 2000 Jul; 39(4):330-3. PubMed ID: 10957774
    [TBL] [Abstract][Full Text] [Related]  

  • 2. American Cancer Society--National Prostate Cancer Detection Project. Results from multiple examinations using transrectal ultrasound, digital rectal examination, and prostate specific antigen.
    Mettlin C; Murphy GP; Ray P; Shanberg A; Toi A; Chesley A; Babaian R; Badalament R; Kane RA; Lee F
    Cancer; 1993 Feb; 71(3 Suppl):891-8. PubMed ID: 7679042
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of Digital Rectal Examination and Serum Prostate Specific Antigen in the Early Detection of Prostate Cancer: Results of a Multicenter Clinical Trial of 6,630 Men.
    Catalona WJ; Richie JP; Ahmann FR; Hudson MA; Scardino PT; Flanigan RC; DeKernion JB; Ratliff TL; Kavoussi LR; Dalkin BL; Waters WB; MacFarlane MT; Southwick PC
    J Urol; 2017 Feb; 197(2S):S200-S207. PubMed ID: 28012755
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of digital rectal examination and serum prostate specific antigen in the early detection of prostate cancer: results of a multicenter clinical trial of 6,630 men.
    Catalona WJ; Richie JP; Ahmann FR; Hudson MA; Scardino PT; Flanigan RC; DeKernion JB; Ratliff TL; Kavoussi LR; Dalkin BL; Waters WB; MacFarlane MT; Southwick PC
    J Urol; 1994 May; 151(5):1283-90. PubMed ID: 7512659
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Early detection of prostate cancer in Germany: a study using digital rectal examination and 4.0 ng/ml prostate-specific antigen as cutoff.
    Luboldt HJ; Bex A; Swoboda A; Hüsing J; Rübben H;
    Eur Urol; 2001 Feb; 39(2):131-7. PubMed ID: 11223671
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Serum prostate-specific antigen and digital rectal examination for early detection of prostate cancer in a national community-based program. The Prostate Cancer Education Council.
    Crawford ED; DeAntoni EP; Etzioni R; Schaefer VC; Olson RM; Ross CA
    Urology; 1996 Jun; 47(6):863-9. PubMed ID: 8677578
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of patient age on early detection of prostate cancer with serum prostate-specific antigen and digital rectal examination.
    Richie JP; Catalona WJ; Ahmann FR; Hudson MA; Scardino PT; Flanigan RC; deKernion JB; Ratliff TL; Kavoussi LR; Dalkin BL; Waters WB; MacFarlane MT; Southwick PC
    Urology; 1993 Oct; 42(4):365-74. PubMed ID: 7692657
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Clinical utility of available diagnostic tests in prostatic carcinoma. Results of 500 biopsies. II. Rectal palpation, PSA, and transrectal echography].
    Rodríguez Rodríguez R; Mayayo Dehesa T; Galbis Sanjuan F; Jiménez Cidre M; Burgos Revilla FJ; Gómez dos Santos V; García González R
    Arch Esp Urol; 1997 May; 50(4):339-45. PubMed ID: 9313042
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Free prostate-specific antigen improves prostate cancer detection in a high-risk population of men with a normal total PSA and digitalrectal examination.
    Uzzo RG; Pinover WH; Horwitz EM; Parlanti A; Mazzoni S; Raysor S; Mirchandani I; Greenberg RE; Pollack A; Hanks GE; Watkins-Bruner D
    Urology; 2003 Apr; 61(4):754-9. PubMed ID: 12670560
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Early recognition of prostate carcinoma. Initial results of a prospective multicenter study in Germany. Project Group for Early Detection DGU-BDU Laboratory diagnosis Professional Circle].
    Luboldt HJ; Altwein JE; Bichler KH; Czaja D; Hüsing J; Fornara P; Jöckel KH; Lübben G; Schalkhäuser K; Weissbach L; Wirth M; Rübben H
    Urologe A; 1999 Mar; 38(2):114-23. PubMed ID: 10231930
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Statistical study of probabilities of rectal palpation, total PSA, and PSA density in prostate cancer].
    Ortiz Cabria R; Adriazola Semino M; Tejeda Bañez E; Alonso Villalba A; García Cobo E; Romero Rodríguez F; Monfá Bosch JM
    Arch Esp Urol; 2002; 55(1):35-40. PubMed ID: 11957749
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Value of PSA (prostate-specific antigen) in the detection of prostate cancer in patients with urological symptoms. Results of a multicentre study.
    Filella X; Molina R; Ballesta AM; Gil MJ; Allepuz C; Rioja LA
    Eur J Cancer; 1996 Jun; 32A(7):1125-8. PubMed ID: 8758241
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Relation of age and prostatic volume to cancer detection in prostatic biopsies from patients with non-suspect rectal palpation].
    Herranz Amo F; Verdú Tartajo F; Díez Cordero JM; Subira Ríos D; Castaño González I; Moralejo Gárate M; Martínez Salamanca JI; Cabello Benavente R
    Arch Esp Urol; 2003 May; 56(4):359-66. PubMed ID: 12830608
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Digital rectal examination, transrectal ultrasonography and prostate specific antigen for diagnosis of prostate cancer in clinical urological practice-detection of impalpable cancer].
    Yamazaki H; Yoshigoe F; Kobari T; Takeuchi H; Katoh N; Ohishi Y
    Nihon Hinyokika Gakkai Zasshi; 1999 Jun; 90(6):595-601. PubMed ID: 10422433
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation of prostatic specific antigen and digital rectal examination as screening tests for prostate cancer.
    Candas B; Cusan L; Gomez JL; Diamond P; Suburu RE; Lévesque J; Brousseau G; Bélanger A; Labrie F
    Prostate; 2000 Sep; 45(1):19-35. PubMed ID: 10960839
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The percentage of free prostatic-specific antigen is also useful in men with normal digital rectal examination and serum prostatic-specific antigen between 10.1 and 20 ng/ml.
    Morote J; Trilla E; Esquena S; Serrallach F; Abascal JM; Muñoz A; Id M'Hammed Y; de Torres IM
    Eur Urol; 2002 Oct; 42(4):333-7. PubMed ID: 12361897
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Diagnosis of prostate cancer: comparison of serum prostate specific antigen, digital rectal examination and transrectal ultrasonography.
    Tsui KH; Chang PL; Wang TM; Hsieh ML
    Changgeng Yi Xue Za Zhi; 1997 Mar; 20(1):23-8. PubMed ID: 9178589
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Value of determining prostate-specific antigen for early detection or prostatic carcinoma].
    Hammerer P; Huland H
    Urologe A; 1995 Jul; 34(4):283-9. PubMed ID: 7545842
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prostate cancer screening within a prostate specific antigen range of 3 to 3.9 ng./ml.: a comparison of digital rectal examination and free prostate specific antigen as supplemental screening tests.
    Mäkinen T; Tammela TL; Hakama M; Stenman UH; Rannikko S; Aro J; Juusela H; Määttänen L; Auvinen A
    J Urol; 2001 Oct; 166(4):1339-42. PubMed ID: 11547069
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prostate cancer detection at low prostate specific antigen.
    Schröder FH; van der Cruijsen-Koeter I; de Koning HJ; Vis AN; Hoedemaeker RF; Kranse R
    J Urol; 2000 Mar; 163(3):806-12. PubMed ID: 10687982
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.